Objective: To investigate the predictive value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) quantitative parameters for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer. Methods: Sixty-five patients with locally advanced gastric cancer (LAGC) confirmed by gastroscopy and received neoadjuvant chemotherapy (NCT) were enrolled in this study. Quantitative DCE-MRI was performed before NCT, and the quantitative parameters were measured, including volume transfer constant (K(trans)), rate constant (K(ep)), volume fraction of extravascular extracellular space (V(e)) and volume fraction of plasma (V(p)). After NCT, all patients received radical gastrectomy. According to postoperative pathological tumor regression grade, patients were divided into response group and non-response group, and the differences of DCE quantitative parameters between the two groups were compared. ROC curve was utilized to analyze the predictive efficacy of DCE quantitative parameters for NCT response of LAGC, and multivariate logistic regression analysis was performed to analyze the predictive efficacy of combined parameters. Results: Thirty-seven patients were in response group and 28 patients were in non-response group. The pretreatment K(trans) in the response group were [0.216 min(-1) (0.130 min(-1), 0.252 min(-1))], significantly higher than [0.091 min(-1) (0.069 min(-1), 0.146 min(-1))] of non-response group (P<0.001), and V(e) in the response group were [0.354(0.228, 0.463)], significantly higher than [0.200(0.177, 0.253)]of non-response group (P<0.001). ROC analysis showed the AUCS of K(trans) and V(e) in predicting NCT efficacy were 0.881 and 0.756, respectively. Multiple logistic regression analysis showed that the combination of the two parameters could improve the AUC to 0.921, with the sensitivity and specificity of 86.5% and 89.3%, respectively. Conclusion: DCE-MRI quantitative parameters could help to predict the NCT response of LAGC, and the combination of parameters could improve the predictive efficacy.
目的: 探讨动态增强磁共振成像(DCE-MRI)定量参数对局部进展期胃癌新辅助化疗疗效的预测价值。 方法: 收集65例经胃镜检查病理证实的局部进展期胃癌并行新辅助化疗的患者,于治疗前行DCE-MRI检查,测量DCE-MRI定量参数,包括容量转移常数(K(trans))、速率常数(K(ep))、血管外细胞外间隙容积比(V(e))和血浆容积分数(V(p))。新辅助化疗结束后接受根治性胃切除术,根据术后病理学肿瘤消退分级,将患者分为治疗有反应组和无反应组,比较两组患者间DCE定量参数的差异。应用受试者工作特征(ROC)曲线分析DCE定量参数对局部进展期胃癌新辅助化疗疗效的预测效能,并应用多因素logistic回归分析参数的联合预测效能。 结果: 65例患者中,治疗有反应组37例,无反应组28例。治疗有反应组患者治疗前肿瘤原发灶的K(trans)值为0.216 min(-1)(0.130 min(-1), 0.252 min(-1)),高于无反应组[0.091 min(-1) (0.069 min(-1), 0.146 min(-1))],差异有统计学意义(P<0.001);治疗有反应组患者的V(e)值为0.354(0.228, 0.463),高于无反应组[0.200(0.177, 0.253)],差异有统计学意义(P<0.001)。ROC曲线分析显示,K(trans)和V(e)值预测化疗后有反应的ROC曲线下面积(AUC)分别为0.881和0.756。多因素logistic回归分析显示,联合两者可将AUC提高至0.921,灵敏度和特异度分别为86.5%和89.3%。 结论: DCE-MRI定量参数有助于预测局部进展期胃癌新辅助化疗的疗效,参数联合应用可以提高预测效能。.
Keywords: Dynamic contrast-enhancement; Efficacy; Gastric neoplasms; Magnetic resonance imaging; Neoadjuvant chemotherapy.